Vitality Watch

Dossier pubmed review 14-aug-2026
Narrative review or expert overview without new data

Proteomics of aging: biomarkers for physiological systems and diseases.

Key claim: Circulating proteomic biomarkers and multi-protein aging clocks quantify biological rather than chronological age and predict frailty, multimorbidity, organ-specific aging, and mortality across physiological systems.

Abstract

Aging is a progressive, multisystem process characterized by declining physiological resilience and increased susceptibility to chronic diseases. Recent advances in high-throughput proteomics have enabled comprehensive mapping of age-related changes across circulating proteins, revealing dynamic and non-linear trajectories that reflect biological rather than chronological aging. This review synthesizes current evidence on proteomic biomarkers across major physiological systems, including the immune, metabolic/endocrine, cardiovascular, musculoskeletal, and nervous systems, and highlights shared molecular signatures that underpin multisystem decline. Robust biomarkers such as IL-6, CRP, CXCL9/10, GDF15, IGF-1, VCAM-1, NT-proBNP, NfL, and GFAP consistently track inflammatory activation, mitochondrial and metabolic stress, extracellular matrix remodeling, and neuro-glial injury. Large population cohorts demonstrate that proteomic aging clocks, leveraging dozens to hundreds of circulating proteins, can predict frailty, multimorbidity, organ-specific biological age, and mortality with high accuracy. Emerging evidence suggests that a limited set of cross-system “protein aging modules”-including inflammatory cytokines, chemokines, complement proteins, and ECM-modifying enzymes-may serve as integrative readouts and potential regulators of aging biology. We discuss methodological advances, system-specific mechanisms, and translational applications of proteomic aging models. Together, these findings position proteomics as a powerful tool for quantifying biological age, identifying early disease risk, and guiding precision interventions to promote healthier aging.

Why this matters

Circulating proteomic biomarkers and multi-protein aging clocks quantify biological rather than chronological age and predict frailty, multimorbidity, organ-specific aging, and mortality across physiological systems.

Source

Link

Briefing card

Proteomics of aging: biomarkers for physiological systems and diseases.
Stage: review · pubmed · 14-aug-2026

Circulating proteomic biomarkers and multi-protein aging clocks quantify biological rather than chronological age and predict frailty, multimorbidity, organ-specific aging, and mortality across physiological systems.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3389/fragi.2026.1895104

build build 880 · 2bcef25 · 2026-11-18